Clinical Trial Update: Gene Expression Following Short Term Exposure to Neoadjuvant Endocrine Therapy in Invasive Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial examining gene expression changes in invasive breast cancer after short-term exposure to neoadjuvant endocrine therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED